Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.7.0.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2017
May 05, 2017
Document And Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q1  
Trading Symbol SGMO  
Entity Registrant Name SANGAMO THERAPEUTICS, INC  
Entity Central Index Key 0001001233  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   71,939,193